# Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

> **NCT06406517** · PHASE3 · UNKNOWN · sponsor: **University of California, San Diego** · enrollment: 160 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Gadopiclenol
- **DRUG:** Gadobenate dimeglumine

## Key facts

- **NCT ID:** NCT06406517
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06406517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06406517, "Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06406517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*